Fulcrum Therapeutics (FULC) Other financing activities (2019 - 2020)
Fulcrum Therapeutics (FULC) posted quarterly Other financing activities of -$158000.0 for Q3 2020, up 41.48% quarter-over-quarter from -$270000.0 in Q4 2019.
Fulcrum Therapeutics (FULC) Other financing activities (2019 - 2020) Analysis & Trends
Fulcrum Therapeutics (FULC) has reported Other financing activities for 2 consecutive years, with -$158000.0 the latest figure, recorded in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fulcrum Therapeutics | 285.31 Mn | 285.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -158,000.00 |
| Sep 30, 2020 | -158,000.00 |
| Dec 31, 2019 | -270,000.00 |
| Dec 31, 2019 | -270,000.00 |